% Expired Patents = 75.0

Forward Citations = 6

Loading Chart...

2 inventors (with patents filed for the assignee):

Aaron I Vinik (4 out of 10 patents)

David A Taylor-Fishwick (4 out of 9 patents)

4 patents: Sort by Forward Citations

1. 7442774 - INGAP displacement assays (2008-10-28),

2. 7355024 - Regulatory sequences for modulation of INGAP expression and reporter constructs (2008-04-08),

3. 7166439 - Assay for anti-INGAP antibodies (2007-01-23),

4. 6986994 - INGAP displacement assays (2006-01-17),

Company Overview

Gmp Endotherapeutics, Inc. is a pharmaceutical company specializing in developing innovative treatments for endocrine disorders. With a focus on endotherapeutics, the company is dedicated to providing high-quality medications to improve the lives of patients. Their cutting-edge research and development efforts aim to address unmet medical needs in the field of endocrinology.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#101 in Fort Lauderdale, FL

#2,106 in Florida

#60,671 in US

Fort Lauderdale, FL, United States of America

Gmp Endotherapeutics, Inc.

Forward Citations = 6

2 inventors:

Aaron I Vinik (4 out of 10 patents)

David A Taylor-Fishwick (4 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Gmp Endotherapeutics, Inc.. Retrieved from https://idiyas.com/company/gmp-endotherapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]